Insmed (INSM) Other Operating Expenses (2011 - 2026)
Insmed (INSM) recorded quarterly Other Operating Expenses of $2.5 million in Q1 2026, down 97.81% quarter-over-quarter from $116.2 million in Q4 2025, and down 93.78% on a YoY basis from $40.8 million in Q1 2025.
Insmed (INSM) Other Operating Expenses (2011 - 2026) Analysis & Trends
Insmed's Other Operating Expenses history runs 12 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 93.78% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $342.6 million (up 58.26% YoY), while the FY2025 annual figure was $380.9 million, up 108.76% from the prior year.
- Other Operating Expenses was $2.5 million for Q1 2026 at Insmed, down from $116.2 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $135.6 million in Q3 2025 to a low of $1.8 million in Q1 2022.
- Historically, Other Operating Expenses has averaged $41.4 million across 5 years, with a median of $27.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses surged 821.17% in 2025, then sank 93.78% in 2026.
- A 5-year view of Other Operating Expenses shows it stood at $12.5 million in 2022, then jumped by 182.5% to $35.4 million in 2023, then plunged by 64.37% to $12.6 million in 2024, then soared by 821.17% to $116.2 million in 2025, then slumped by 97.81% to $2.5 million in 2026.
- The last three Other Operating Expenses figures came in at $2.5 million (Q1 2026), $116.2 million (Q4 2025), and $135.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Insmed | 21.32 Bn | 20.09 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54 Mn |
| Dec 31, 2025 | 116.20 Mn |
| Sep 30, 2025 | 135.56 Mn |
| Jun 30, 2025 | 88.34 Mn |
| Mar 31, 2025 | 40.84 Mn |
| Dec 31, 2024 | 12.61 Mn |
| Sep 30, 2024 | 37.12 Mn |
| Jun 30, 2024 | 125.93 Mn |
| Mar 31, 2024 | 6.82 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Sep 30, 2023 | 26.97 Mn |
| Jun 30, 2023 | 31.36 Mn |
| Mar 31, 2023 | 5.59 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 13.58 Mn |
| Sep 30, 2021 | 19.75 Mn |
| Jun 30, 2021 | 12.10 Mn |